Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroids and/or NSAIDs in the postoperative regimen after trabeculectomy (SNAP)
2025-523957-32-00Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lisinopril + hydrochlorothiazide, diclofenac and dexamethasone in open-angle glaucoma (OAG), pseudoexfoliation syndrome (PXF), pigment dispersion syndrome (PDS) and 1 more (3 arms), sponsored by Rigshospitalet. Primary endpoint: Primary intraocular pressure at 12 months. Started Oct 2025; status: completed.
02
Drugs
lisinopril + hydrochlorothiazidediclofenacdexamethasone
03
Conditions
open-angle glaucoma (OAG)pseudoexfoliation syndrome (PXF)pigment dispersion syndrome (PDS)ocular hypertension
Beyond the preview
Go deeper on 2025-523957-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523957-32-00.